Journal of the American Chemical Society
COMMUNICATION
Table 4. Aldol Reaction at Low Catalyst Loadings
Scheme 3. Hydrolysis of Oxazolines
Scheme 4. Reductive Manipulation of Oxazoline 9d
2
Ag2O
time
conv
(%)a
yield
(%)b
ee
(%)c
entry (mol %) (mol %) (h)
dra
1
2
2
2
1
24
24
100
100
44
90
1:1
48
94
0.5
14:1
a Determined by H NMR analysis. b Isolated yield of major diaster-
1
eomer. c ee of the major diastereomer determined by chiral HPLC.
not apparent, this suggests that the mode of action of our catalytic
system differs from the seminal findings of Ito and Togni.4a,4b One
possible rationale for this observation could be that the diastereo-
mers are interconverting under the reaction conditions. However,
when an enantioenriched sample of (4R,5R)-9c was treated with
amino-phosphine 2 and Ag2O under the optimized conditions,
no epimerization or racemization was observed. When the minor
diastereomer obtained during the formation of (4R,5R)-9c was
treated in the same manner, no epimerization was observed.
We then turned our attention to the possibility of lowering the
catalyst loading. When oxazoline (4R,5R)-9c was prepared using
2 mol % of precatalyst2 and 1 mol % of Ag2O, the reaction occurred
smoothly, but the product was obtained in 48% enantiomeric excess
(entry 1, Table 4). In order to restore high levels of enantioselec-
tivity, the loading of Ag2O had to be further lowered to 0.5 mol %,
keeping the precatalyst loading at 2 mol % (entry 2, Table 4). We
postulate that at low catalyst loadings, isocyanoacetate 8a competes
with precatalyst 2 in the Agþ complexation and a non-asymmetric
pathway is occurring. In order to minimize the background and
restore high levels of enantioselectivity, the ratio of 2:Ag2Ohadtobe
changed from 2:1 to 4:1.
enantioselectivities. The possibility of lowering the catalyst loading
has been investigated, and good levels of reactivity and stereo-
control can be obtained with a combination of 2 mol % of ligand 2
and 0.5 mol % of Ag2O. Work to probe the origin of stereocontrol
and to uncover further catalytic applications of ligands 1-4 is
under investigation in our laboratories and will be reported in due
course.
’ ASSOCIATED CONTENT
S
Supporting Information. Experimental procedures and
b
spectral data for compounds 1-4, 7a-h, 9a-h, 11-13 and CIF
files for compounds 9c and 13. This material is available free of
’ AUTHOR INFORMATION
Corresponding Author
’ ACKNOWLEDGMENT
To highlight the utility of the isocyanoacetate aldol reaction
products in synthesis, we explored their conversion to the
corresponding amino acid derivatives. For example, a mild
methanolysis allowed the conversion of oxazoline (4R,5S)-7a
directly to the corresponding tert-butyl ester 10, proving the
utility of our method for the direct preparation of protected
β-hydroxy-R-amino acid tert-butyl esters (Scheme 3). Hydrolysis
of 10 gave the parent amino acid in quantitative yield; this enabled
assignment of the absolute stereochemistry by comparison of its
specific rotationwith those reportedinthe literature.4a,8 Reduction
of 9d with LiAlH4 furnished amino alcohol 12, which was further
derivatized to oxazolidinone 13 (Scheme 4) in order to assign
absolute stereochemistry of 9a-h by single-crystal X-ray analysis.
In summary, we have developed a new class of chiral amino-
phosphine precatalysts that, in combination with an appropriate
transition metal ion, can perform as effective cooperative Brønsted
base/Lewis acid catalysts. This concept has been successfully
applied to the highly enantio- and diastereoselective aldol reaction
of isocyanoacetate nucleophiles in the presence of Ag(I) salts. The
protocol proved to be operationally simple and could be per-
formed by mixing together the ligand and Ag2O, without the need
to preform the active catalytic species. The catalytic system
proved particularly effective in inducing high levels of stereocon-
trol with aromatic and branched aliphatic aldehydes, while linear
aliphatic aldehydes furnished the desired products with lower
We thank the EPSRC (Leadership Fellowship to D.J.D.), the
EC [IEF to F.S. (PIEF-GA-2009-254068)], Andrew Kyle, of the
Department of Chemistry, University of Oxford, for X-ray
analysis, and the Oxford Chemical Crystallography Service for
the use of the instrumentation.
’ REFERENCES
(1) For recent reviews see: (a) Paull, D. H.; Abraham, C. J.; Scerba,
M. T.; Alden-Danforth, E. T.; Lectka, T. Acc. Chem. Res. 2008, 655.
(b) Kanai, M.; Kato, N.; Ichikawa, E.; Shibasaki, M. Synlett 2005, 10, 1491.
(c) Gr€utmacher, H. Angew. Chem., Int. Ed. 2008, 47, 1814. (d) Park, J. P.;
Park, J. W.; Jun, C. H. Acc. Chem. Res. 2008, 222. (e) Ma, J. A.; Cahard, D.
Angew. Chem., Int. Ed. 2004, 44, 4566. (f) Ikariya, T.; Murata, K.; Noyori, R.
Org. Biomol. Chem. 2006, 4, 393. (g) Mu~niz, K. Angew. Chem., Int. Ed. 2005,
44, 6622. (h) Kanai, M.; Kato, N.; Ichikawa, E.; Shibasaki, M. Pure Appl.
Chem. 2005, 77, 2047.
(2) (a) Yang, T.; Ferrali, A.; Sladojevich, F.; Dixon, D. J. J. Am. Chem.
Soc. 2009, 131, 9140. For selected applications of 9-amino(9-deoxy)
epicinchona-derived (thio)urea bifunctional organocatalysts see: (b) Ye,
J.-X.; Dixon, D. J.; Hynes, P. S. Chem. Commun. 2005, 4481. (c) Hynes,
P. S.; Stranges, D.; Stupple, P. A.; Guarna, A.; Dixon, D. J. Org. Lett. 2007,
9, 2107. (d) Hynes, P. S.; Stupple, P. A.; Dixon, D. J. Org. Lett. 2008, 10,
1389. (e) Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc.
2009, 131, 16632.
(3) Hoppe, D.; Sch€ollkopf, U. Liebigs Ann. Chem. 1972, 763.
1712
dx.doi.org/10.1021/ja110534g |J. Am. Chem. Soc. 2011, 133, 1710–1713